Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON CIPLA BIOCON /
CIPLA
 
P/E (TTM) x 19.7 32.5 60.7% View Chart
P/BV x 1.8 5.2 34.6% View Chart
Dividend Yield % 0.6 0.6 100.5%  

Financials

 BIOCON    CIPLA
EQUITY SHARE DATA
    BIOCON
Mar-23
CIPLA
Mar-23
BIOCON /
CIPLA
5-Yr Chart
Click to enlarge
High Rs3881,185 32.7%   
Low Rs192852 22.5%   
Sales per share (Unadj.) Rs93.1281.9 33.0%  
Earnings per share (Unadj.) Rs5.435.1 15.2%  
Cash flow per share (Unadj.) Rs14.649.7 29.5%  
Dividends per share (Unadj.) Rs1.508.50 17.6%  
Avg Dividend yield %0.50.8 62.0%  
Book value per share (Unadj.) Rs146.5289.2 50.7%  
Shares outstanding (eoy) m1,200.60807.15 148.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.13.6 86.1%   
Avg P/E ratio x54.129.0 186.6%  
P/CF ratio (eoy) x19.820.5 96.5%  
Price / Book Value ratio x2.03.5 56.1%  
Dividend payout %28.024.2 115.8%   
Avg Mkt Cap Rs m347,814822,164 42.3%   
No. of employees `000NANA-   
Total wages/salary Rs m21,81038,301 56.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,742227,531 49.1%  
Other income Rs m7,6815,121 150.0%   
Total revenues Rs m119,423232,653 51.3%   
Gross profit Rs m16,61148,079 34.5%  
Depreciation Rs m11,13111,721 95.0%   
Interest Rs m4,1901,095 382.5%   
Profit before tax Rs m8,97140,384 22.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,54112,029 21.1%   
Profit after tax Rs m6,43028,355 22.7%  
Gross profit margin %14.921.1 70.4%  
Effective tax rate %28.329.8 95.1%   
Net profit margin %5.812.5 46.2%  
BALANCE SHEET DATA
Current assets Rs m123,340168,051 73.4%   
Current liabilities Rs m85,10750,333 169.1%   
Net working cap to sales %34.251.7 66.1%  
Current ratio x1.43.3 43.4%  
Inventory Days Days12973 176.1%  
Debtors Days Days1177 1,793.4%  
Net fixed assets Rs m394,078117,318 335.9%   
Share capital Rs m6,0031,614 371.9%   
"Free" reserves Rs m169,926231,845 73.3%   
Net worth Rs m175,929233,460 75.4%   
Long term debt Rs m152,9050-   
Total assets Rs m517,418290,067 178.4%  
Interest coverage x3.137.9 8.3%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.20.8 27.5%   
Return on assets %2.110.2 20.2%  
Return on equity %3.712.1 30.1%  
Return on capital %4.017.8 22.5%  
Exports to sales %3.122.6 13.7%   
Imports to sales %6.08.9 67.1%   
Exports (fob) Rs m3,46751,516 6.7%   
Imports (cif) Rs m6,65420,202 32.9%   
Fx inflow Rs m3,46764,282 5.4%   
Fx outflow Rs m6,65420,202 32.9%   
Net fx Rs m-3,18744,080 -7.2%   
CASH FLOW
From Operations Rs m18,52532,377 57.2%  
From Investments Rs m-142,818-23,885 597.9%  
From Financial Activity Rs m130,487-9,583 -1,361.7%  
Net Cashflow Rs m6,411-968 -662.4%  

Share Holding

Indian Promoters % 40.4 13.4 300.5%  
Foreign collaborators % 20.3 20.0 101.2%  
Indian inst/Mut Fund % 21.1 50.0 42.1%  
FIIs % 6.6 25.7 25.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 66.5 59.2%  
Shareholders   434,339 425,731 102.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Biocon vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Cipla Share Price Performance

Period Biocon Cipla S&P BSE HEALTHCARE
1-Day 3.20% 2.89% 1.45%
1-Month -2.27% 2.19% -0.48%
1-Year 30.86% 69.59% 62.25%
3-Year CAGR -13.47% 22.91% 18.26%
5-Year CAGR -2.67% 23.46% 19.85%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Biocon, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.